Caring for someone with multiple myeloma can be challenging on many levels. The person who has just been diagnosed may look to you for information to help them better understand the disease to ...
Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple myeloma treatment paradigm, the drug is still finding ways to consolidate its ...
In a new study published in Cancer, researchers from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine’s Department of Pathology examine this disparity more closely, ...
The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple myeloma, explained Roberto Mina, MD. While teclistamab originally received ...
The UEFA Champions League is set to wrap up its league phase this Wednesday, January 28, with a decisive eighth matchday played in a spectacular multiplex format. At 9 p.m., eighteen matches will be ...
How Does Multiple Myeloma Impact the Kidneys? Multiple myeloma is a cancer of plasma cells, a type of immune cell found in bone marrow. Healthy plasma cells make proteins called antibodies to fight ...
In a retrospective study, the non-relapse mortality rate at 1 year was 17% in those with CAR T-cell therapy-associated immune-related adverse events versus 2.7% in those without such events.
Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II) For over half a ...
Concourse Plaza Multiplex Cinemas in the Bronx is closing its curtains for good Tuesday night after more than three decades in business. In a statement, the movie theater on East 161st Street in ...
3D multiplexed imaging in cancer immunology enables a better characterization of tissue changes and cell interactions. Here, we introduce a one-shot, high-multiplexing workflow on the STELLARIS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results